Fortive Corporation (FTV)

FairStock Score: 39/100 — MIXED

Key Financials

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

I look for businesses that earn good returns and sell at a sensible price. Fortive is a real industrial technology company, with instruments, software, and services in intelligent operating and advanced healthcare. Its filed figures show fiscal year 2025, the year ended 2025-12-31, revenue of $4.2B, net income of $579.2M, and diluted EPS of $1.73, down from fiscal year 2024, the year ended 2024-12-31, net income of $832.9M and EPS of $2.36. Revenue edged up from $3.9B in fiscal year 2023, the year ended 2023-12-31, to $4.2B in fiscal year 2025, but the profit trend is not reassuring. I cannot verify a durable moat from these figures alone: ROE is 7.32%, ROCE is 3.29%, and profits have fallen. The supplied FairStock category is slow grower - shrinking, based on five-year profit decline of 18.5% a year and revenue decline of 2.1%. On the positive side, trailing free cash flow is $1.1B and the FCF yield is 5.7%; the Piotroski F-score is 8/9, and debt-to-equity is 0.59. At the 2026-10-26 close of $60.78, FairStock calculates P/E of 32.16, P/B of 3.03, EV/EBITDA of 17.34, and a Graham Number of $29.19, so the price is about 106% above that conservative value. The FairStock score is 39/100. Quality may be improving on cash flow and balance sheet, but the earnings record and valuation leave little margin of safety. I would want to see profit stabilization and better returns before calling this a bargain.

In plain English: Fortive makes scientific and technical instruments, software, and services for industrial and healthcare customers. It generates solid cash, but reported profits have weakened recently, and the shares look expensive compared with the company's earnings and assets.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data as of 2026-10-26 close · note generated 2026-10-28 · model deepseek-flash

Sources (SEC EDGAR): fiscal Q1 2026 10-Q (period ended 2026-04-03) · fiscal Q4 2025 10-K (period ended 2025-12-31) · fiscal Q3 2025 10-K (period ended 2025-09-26) · fiscal Q2 2025 10-K (period ended 2025-06-27) · FY2025 10-K (period ended 2025-12-31) · FY2024 10-K (period ended 2024-12-31) · FY2023 10-K (period ended 2023-12-31)

Fundamentals from company filings and market-data providers; prices are end-of-day, not real-time. AI-generated analysis is general and educational — not personal investment advice. Scoring methodology · Score test · Disclaimer